SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines ...
DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...
Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback